<DOC>
	<DOCNO>NCT02221700</DOCNO>
	<brief_summary>The goal research study compare level effectiveness two massage treatment schedule chronic CIPN people treat Oxaliplatin taxanes ( docetaxel , paclitaxel ) cancer ( breast gastrointestinal ) . Researchers also want study participant may respond massage treatment , treatment may affect quality life physical performance .</brief_summary>
	<brief_title>Massage Chemotherapy Induced Peripheral Neuropathy ( CIPN )</brief_title>
	<detailed_description>Peripheral neuropathy one common chemotherapy side effect affect nerve . Each year , thousand patient receive oxaliplatin-based taxane-based chemotherapy 50 % patient Chemotherapy Induced Peripheral Neuropathy ( CIPN ) . CIPN cause painful abnormal skin sensation ( pin needle ) , numbness , and/or nerve damage may affect movement . Study Groups : If find eligible take part study , randomly assign ( roll dice ) 1 4 group . The location massage massage schedule vary group . You either massage 3 time week 4 week 2 time week 6 week . Massage Treatments ( All Participants ) : Your massage treatment give outpatient basis private room . For massage , either lie table sit recline chair . The total time 30 minute , include position chair table . Study Visits : One ( 1 ) time every week : - Your vital sign measure . - You ask drug may take side effect may . At Weeks 4 , 6 , 8 10 : - You complete 5 questionnaire . - You perform leg function balance test . Length Study : You may continue participation study 10 week , long study doctor think best interest . Your active participation study complete follow-up visit . Follow-Up Visit : After complete final massage treatment , follow test and/or procedure perform : - Your vital sign measure . - Your medical history record . - You ask drug may take side effect may . - You complete 5 questionnaire . - You perform leg function balance test . - You complete brief exit interview ask question think benefit massage . This interview take 10 minute complete . This investigational study . The use massage treatment chronic CIPN investigational . Up 90 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>1 . All gastrointestinal malignancy patient receive oxaliplatin cancer treatment breast malignancy patient receive docetaxel paclitaxel cancer treatment . 2 . Greater equal 6 month last chemotherapy treatment . 3 . Must understand read English , sign write informed consent , follow protocol requirement . 4 . Age great equal 18 year 5 . Must willing come MD Anderson Main Campus ( Texas Medical Center ) intervention . 6 . Lower extremity neuropathy per patient report attributable oxaliplatin , docetaxel paclitaxel ( neurotoxic chemotherapeutic agent ) determine patient history neurotoxic agent administration history attributable cause diabetic neuropathy . 7 . Patient selfreport neuropathy score great equal 3 0 10 numeric scale and/or Grade 2 3 neuropathy ( accord National Cancer Institute Common Toxicity Criteria 4 point grade scale ) . 8 . Within 2 week prior study enrollment patient must stable dose medication management CIPN symptom . For least 2 week prior enrollment Stable dose define : 1 ) No change drug class ; 2 ) Increases decrease less equal 20 % total dosage . All drug class allowed.. 1 . Patients previously diagnose peripheral neuropathy pre date neurotoxic chemotherapy administration cause chemotherapy . 2 . Platelets le 50,000 neutrophil count le 500 within 6 month prior study enrollment . 3 . Deep venous thrombosis ( DVT ) diagnose within 12 month study enrollment history untreated low extremity DVT , bone metastasis , currently active skin infection , lymphedema currently involve treatment field . 4 . Women pregnant time enrollment . Pregnancy assess enrollment use urine pregnancy test . 5 . Diagnosis diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Gastrointestinal cancer</keyword>
	<keyword>Chemotherapy Induced Peripheral Neuropathy</keyword>
	<keyword>CIPN</keyword>
	<keyword>Symptom reduction</keyword>
	<keyword>Massage</keyword>
	<keyword>Symptom questionnaire</keyword>
	<keyword>Surveys</keyword>
	<keyword>Leg function balance test</keyword>
</DOC>